Baxter International Inc $74.29

down -0.69


2/9/2014 04:00 PM  |  NYSE : BAX  
Industries : Health Services / Medical Instruments & Supplies
Get Trend Analysis Icon Get BAX Trend Analysis - it has underperformed the S&P 500 by 16%

Partner Headlines

  1. Abbott: A Brighter Future

    GuruFocus
  2. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives

    Benzinga
  3. Halozyme Therapeutics Receives Favorable FDA Decision

    Benzinga
  4. Merck, J&J, Baxter Provide Healthy Dividend Stream

    IBD
  5. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga
  6. Quarterly “Beats”: Bah, Here Are Real Growers

    YCharts
  7. Diamond Hill Capital Comments on Baxter International Inc

    GuruFocus
  8. Baxter Q2 Earnings Beat Estimates, But Guidance Soft

    IBD
  9. Earnings Scheduled For July 17, 2014

    Benzinga
  10. Hemophilia Drugs, Gambro Deal Boost Baxter's Growth

    IBD
  11. Biogen Hemophilia Drugs Launch Into The Unknown

    IBD
  12. Why I Bought Baxter International

    GuruFocus
  13. Grifols Grows Into New Markets, Products Via Buyouts

    IBD
  14. Cyberonics Shocks Investors With Weak Profit Guidance

    IBD
  15. Becton, Dickinson and Co. (BDX) Dividend Stock Analysis

    GuruFocus
  16. 7 Stocks Building Shareholder Returns with Higher Dividends

    GuruFocus
  17. Medical Devices Face Onslaught Of Pricing Pressure

    IBD
  18. Earnings Scheduled For April 17, 2014

    Benzinga
  19. Baxter Announces Primary Efficacy Endpoint for Phase 3 Trial of BAX 11 ...

    Benzinga
  20. 4 Top Stocks in the Medical Device Sector

    GuruFocus
  21. Analysts Warm To Baxter's Split Announcement

    IBD
  22. Alarming Spinoff: ADT Debt Soars, Stock Plunges

    YCharts
  23. We Are Confident About Baxter's Plan to Create Two Separate Health Care ...

    GuruFocus
  24. For The Record

    IBD
  25. Morgan Stanley Welcomes Shift in Sentiment on Baxter International

    Benzinga
  26. Not Too Late to Buy Baxter, Jim Cramer Says

    Benzinga
  27. Baxter To Split In 2 By 2015

    IBD
  28. Market Wrap For March 27: Markets Lower Following Mixed Economic Data

    Benzinga
  29. Mid-Afternoon Market Update: Inovio Rallies on Vaccine Award; Citigroup ...

    Benzinga
  30. Mid-Day Market Update: US Stocks Fall; Citigroup Shares Slip After Failed ...

    Benzinga
  31. Stocks Turn Down Near Midday; Diamondback Tops U.S. Oil Rally

    IBD
  32. Baxter To Split Into Two Companies; Stock Jumps

    IBD
  33. Merck Snags Baxter Executive As CFO

    FoxBusiness
  34. Benzinga's Volume Movers

    Benzinga
  35. Mid-Morning Market Update: Markets Mostly Flat; Lululemon Profit Beats ...

    Benzinga
  36. Stocks Cling To Narrow Gains; Baxter International, Alcoa Up

    IBD
  37. Morgan Stanley Offers Quick Thoughts on Eloctate and Strategic Action Related ...

    Benzinga
  38. Morning Market Movers

    Benzinga
  39. Benzinga's Top #PreMarket Gainers

    Benzinga
  40. Baxter to Split Itself into Two Companies

    FoxBusiness
  41. UPDATE: Baxter Details Plan to Create Two Separate Global Healthcare Cos.

    Benzinga
  42. Which Pharmas Can Keep Up Dividend-Buybacks?

    YCharts
  43. Market Wrap For March 17: Investors Focused On Economic Data Instead Of ...

    Benzinga
  44. UPDATE: Goldman Sachs Downgrades Baxter International as Increased Dependence ...

    Benzinga
  45. Morgan Stanley's View of Baxter International is Not Changed by Rigosertib's ...

    Benzinga
  46. How To Invest: Shakeout + 3 Offers Early Entry

    IBD
  47. BAXTER INT'L

    IBD
  48. Earnings Scheduled For January 23, 2014

    Benzinga
  49. Diamond Hill Capital Comments on Baxter International

    GuruFocus
  50. Ligand Pharmaceuticals Poised For Full-Year Profit

    IBD
Trading Center